Finnrick - Ensuring a Safer and More Transparent Supply Chain
Huayi Biotechnology

Huayi Biotechnology

Retatrutide

Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Huayi Biotechnology between 1 Sep 2025 and 9 Oct 2025. Test scores average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).

Finnrick Rating™
C
OKAY
Huayi Biotechnology
Retatrutide
Tested 6 Samples
Last test 9 Oct 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Retatrutide tests from top-rated vendors:

All Retatrutide tests from Huayi Biotechnology

Samples are tested in commercial labs

Tests Count

6

Scores

AVG7.1MIN4.5MAX9.3

Last

9 Oct 2025

First

1 Sep 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
9 Oct 2025View6.515mg14.900mg-0.7%99.26%(no batch ID)No Label / Silver Crimp / Red Cap Lab EPublic
9 Oct 2025View7.830mg29.700mg-1.0%99.83%(no batch ID)No Label / Silver Crimp / Clear Cap Lab EPublic
30 Sep 2025View9.310mg9.280mg-7.2%99.95%August 28, 2025No Label / Silver Crimp / Clear Blue Cap Lab EPublic
9 Sep 2025View4.510mg12.730mg+27.3%99.72%(no batch ID)No Label / Silver Crimp / Clear Blue Cap Lab DPublic
4 Sep 2025View6.920mg21.700mg+8.5%99.95%(no batch ID)No Label / Copper Crimp / Clear Cap Lab EPublic
1 Sep 2025View7.820mg22.480mg+12.4%99.83%Jul 17, 2025No Label / Copper Crimp / Clear CapLab FPublic